Does BEVACIZUMAB Cause Metastases to lung? 578 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 578 reports of Metastases to lung have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.7% of all adverse event reports for BEVACIZUMAB.
578
Reports of Metastases to lung with BEVACIZUMAB
0.7%
of all BEVACIZUMAB reports
146
Deaths
104
Hospitalizations
How Dangerous Is Metastases to lung From BEVACIZUMAB?
Of the 578 reports, 146 (25.3%) resulted in death, 104 (18.0%) required hospitalization, and 16 (2.8%) were considered life-threatening.
Is Metastases to lung Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 578 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Metastases to lung?
LETROZOLE (703)
RIBOCICLIB (649)
CAPECITABINE (616)
PACLITAXEL (563)
FULVESTRANT (560)
EVEROLIMUS (522)
TRASTUZUMAB (458)
DOCETAXEL (415)
FLUOROURACIL (375)
CARBOPLATIN (369)
Which BEVACIZUMAB Alternatives Have Lower Metastases to lung Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ